Literature DB >> 19469903

Expression and regulation of cathepsin K in skin fibroblasts.

Maria J Quintanilla-Dieck1, Katerine Codriansky, Michelle Keady, Jag Bhawan, Thomas M Rünger.   

Abstract

Cathepsin K (catK) is a lysosomal cysteine protease with strong collagenolytic activity well known to mediate bone resorption in osteoclasts. Recently, catK has also been reported to be expressed in other tissues. In the dermis, it is expressed only under certain circumstances such as scarring or inflammation. We therefore investigated the expression and regulation of this protease in dermal fibroblasts using immunoblotting and immunostaining. Cultured skin fibroblasts were found to strongly express catK in lysosomes. Internalization of collagen I and IV to lysosomes of fibroblasts indicates a role of catK in intracellular collagen degradation after endocytosis, a process that is different from the metalloproteinase-mediated collagen degradation in the extracellular space. In fibroblasts, interleukin-1alpha and cellular confluence upregulate catK expression and transforming growth factor-beta1 inhibits confluence-induced catK upregulation in skin fibroblasts. RANKL (ligand of receptor activator of NF-kappaB) did not alter catK expression. These regulators of catK expression are likely to play a role in the as-needed upregulation in certain skin conditions, where the prominent matrix-degrading properties of catK are thought to require tight regulation to maintain the homeostasis of the extracellular matrix.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19469903     DOI: 10.1111/j.1600-0625.2009.00855.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  19 in total

1.  Quantitative proteomics reveals altered expression of extracellular matrix related proteins of human primary dermal fibroblasts in response to sulfated hyaluronan and collagen applied as artificial extracellular matrix.

Authors:  Stephan A Müller; Anja van der Smissen; Margarete von Feilitzsch; Ulf Anderegg; Stefan Kalkhof; Martin von Bergen
Journal:  J Mater Sci Mater Med       Date:  2012-09-19       Impact factor: 3.896

Review 2.  Cathepsin K: its skeletal actions and role as a therapeutic target in osteoporosis.

Authors:  Aline G Costa; Natalie E Cusano; Barbara C Silva; Serge Cremers; John P Bilezikian
Journal:  Nat Rev Rheumatol       Date:  2011-06-14       Impact factor: 20.543

3.  TAK1 is essential for osteoclast differentiation and is an important modulator of cell death by apoptosis and necroptosis.

Authors:  Betty Lamothe; YunJu Lai; Min Xie; Michael D Schneider; Bryant G Darnay
Journal:  Mol Cell Biol       Date:  2012-11-19       Impact factor: 4.272

Review 4.  Cathepsin K Inhibitors for Osteoporosis: Biology, Potential Clinical Utility, and Lessons Learned.

Authors:  Matthew T Drake; Bart L Clarke; Merry Jo Oursler; Sundeep Khosla
Journal:  Endocr Rev       Date:  2017-08-01       Impact factor: 19.871

5.  Modulation of lentiviral vector tropism in cerebellar Purkinje cells in vivo by a lysosomal cysteine protease cathepsin K.

Authors:  Hanna Goenawan; Hirokazu Hirai
Journal:  J Neurovirol       Date:  2012-10-16       Impact factor: 2.643

6.  A novel approach to inhibit bone resorption: exosite inhibitors against cathepsin K.

Authors:  Preety Panwar; Kent Søe; Rafael Vc Guido; Renata V C Bueno; Jean-Marie Delaisse; Dieter Brömme
Journal:  Br J Pharmacol       Date:  2015-12-16       Impact factor: 8.739

7.  The immunoreceptor tyrosine-based activation motif (ITAM) -related factors are increased in synovial tissue and vasculature of rheumatoid arthritic joints.

Authors:  Tania N Crotti; Anak A S S K Dharmapatni; Ekram Alias; Andrew C W Zannettino; Malcolm D Smith; David R Haynes
Journal:  Arthritis Res Ther       Date:  2012-11-12       Impact factor: 5.156

8.  Cathepsin K is present in invasive oral tongue squamous cell carcinoma in vivo and in vitro.

Authors:  Carolina C Bitu; Joonas H Kauppila; Andréia Bufalino; Sini Nurmenniemi; Susanna Teppo; Meeri Keinänen; Suvi-Tuuli Vilen; Petri Lehenkari; Pia Nyberg; Ricardo D Coletta; Tuula Salo
Journal:  PLoS One       Date:  2013-08-07       Impact factor: 3.240

9.  Ultraviolet A-induced cathepsin K expression is mediated via MAPK/AP-1 pathway in human dermal fibroblasts.

Authors:  Qingfang Xu; Wei Hou; Yue Zheng; Chen Liu; Zijian Gong; Chun Lu; Wei Lai; Howard I Maibach
Journal:  PLoS One       Date:  2014-07-21       Impact factor: 3.240

Review 10.  Potential role of odanacatib in the treatment of osteoporosis.

Authors:  Kong Wah Ng
Journal:  Clin Interv Aging       Date:  2012-07-12       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.